| Testing of Residual Formaldehyde - Guidance for Industry (VICH GL 25) |
Guidelines |
2012-12-12 |
HTML |
| Testing of Residual Moisture - Guidance for Industry (VICH GL 26) |
Guidelines |
2011-04-29 |
HTML |
| VB-GL-3.6: Bluetongue virus exclusion testing of veterinary biologics |
Guidelines |
2023-02-21 |
HTML |
| VB-GL-3.31: Pseudorabies virus exclusion testing of veterinary biologics |
Guidelines |
2023-02-21 |
HTML |
| VB-GL-3.28: Requirements for personnel involved in the manufacturing, testing, and importation of veterinary biologics |
Guidelines |
2022-11-30 |
HTML |
| VB-GL-3.1: Preparation of new product licensing (registration) submissions for veterinary biologics |
Guidelines |
2023-02-15 |
HTML |
| VB-GL-3.2: Regulation of biotechnology-derived veterinary biologics |
Guidelines |
2023-06-08 |
HTML |
Veterinary Biologics Guideline 3.3
Labelling of veterinary biologics |
Guidelines |
2021-08-30 |
HTML |
| VB-GL-3.4: Pre-submission consultation meetings and advance notification of new product licensing submissions |
Guidelines |
2023-02-15 |
HTML |
| VB-GL-3.5: Advertising of veterinary biologics |
Guidelines |
2023-02-15 |
HTML |
| VB-GL-3.1.1: Preparation of new product licensing (registration) submissions for veterinary biologics manufactured in Canada |
Guidelines |
2023-02-15 |
HTML |
| VB-GL-3.1.2: Preparation of new product licensing (registration) submissions for veterinary biologics manufactured and/or licensed in the United States |
Guidelines |
2023-02-15 |
HTML |
| VB-GL-3.1.3: Preparation of new product licensing (registration) submissions for veterinary biologics manufactured in foreign countries other than the United States |
Guidelines |
2023-02-15 |
HTML |
| VB-GL-3.7: Preparation of Outline of Production, special outlines and summary of changes |
Guidelines |
2022-10-13 |
HTML |
Veterinary Biologics Guideline 3.11E
Guideline for Inspection of Veterinary Biologics Manufacturers and Importers |
Guidelines, Imports |
2012-02-07 |
HTML |
| VB-GL-3.13: Autogenous veterinary biologics |
Guidelines |
2023-04-13 |
HTML |
| VB-GL-3.15: Reporting suspected adverse events related to veterinary biologics |
Guidelines |
2023-02-02 |
HTML |
| VB-GL-3.33: Requirements for commercial importers of veterinary biologics in Canada |
Guidelines, Imports |
2023-10-30 |
HTML |
| VB-GL-3.32: Minimising the risk of introducing transmissible spongiform encephalopathy prions and other infectious agents through veterinary biologics |
Guidelines |
2023-06-20 |
HTML |
| VB-GL-3.29: Safety requirements for veterinary biologics |
Guidelines |
2023-04-04 |
HTML |
| VB-GL-3.26: Issuance of veterinary biologics export certificates |
Guidelines |
2023-06-08 |
HTML |
| VB-GL-3.16: Registration of immunoglobulin products |
Guidelines |
2023-07-13 |
HTML |
Veterinary Biologics Guideline 3.17E
Guide for Reporting Laboratory and Field Efficacy Trials |
Guidelines |
2013-09-20 |
HTML |
Veterinary Biologics Guideline 3.19:
Guideline for Licensing Veterinary Diagnostic Test Kits in Canada |
Guidelines |
2014-02-25 |
HTML |
Veterinary Biologics Guideline 3.21E:
Guideline for the Importation and/or Release of Unlicensed Veterinary Biologics for Research or Emergency Use |
Guidelines |
2013-12-04 |
HTML |
| VB-GL-3.23: Licensing veterinary nucleic acid vaccines |
Guidelines |
2023-10-30 |
HTML |
Veterinary Biologics Guideline 3.24E
Guidelines for Inspection of Veterinary Biologics Importers |
Guidelines, Imports |
2015-04-23 |
HTML |
| Importation of Veterinary Biologics - Overview |
Guidelines, Imports |
2021-05-26 |
HTML |
| VB-GL-3.21.2: Importation of unlicensed veterinary biologics manufactured in a foreign country |
Guidelines, Imports |
2022-12-12 |
HTML |
Veterinary Biologics Guideline 3.21.1E:
Guideline for the Release of Unlicensed Veterinary Biologics Manufactured in Canada |
Guidelines |
2015-07-06 |
HTML |
| VB-GL-3.22: Master seed stocks, master cell stocks and serial requirements |
Guidelines |
2023-04-04 |
HTML |
| VB-GL-3.34: Requirements for veterinary biologics facilities |
Guidelines, Imports |
2022-11-30 |
HTML |
